News search

Dr. Miguel Torres, of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), leads a new project that will receive €8 million in funding over 5 years, €1,380,000 of which will be directly managed at the CNIC

One of the diseases most affected by aging is cardiovascular illness. In fact, it is already considered the most important risk factor for this disease

The project aims to study how certain mutations acquired in blood cells and traditionally associated with a high risk of developing leukemia can also contribute to the development of cardiovascular disease and become a new and independent cardiovascular risk factor to classical factors

Treatment of mice for 12 months with the anticoagulant drug dabigatran prevented memory loss and preserved cerebral circulation

CNIC researchers have defined the dynamics of  the transfer of mitochondrial DNA from mothers to their offspring

Dra. Ivana Nikolić studies the role of T cells in the development of diseases associated with obesity

The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease